HealthCap (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:
Stockholm, Oslo, Lausanne
Preferred areas of investment:
Biotech Health services
Average round investment:
18.78M USD

HealthCap is a family of venture capital funds investing globally in life sciences. The investment strategy focuses on diseases with high unmet medical needs and breakthrough therapies that have the potential to be transformative and change medical practice, and the lives of patients suffering these conditions.

We tracked 12 Nordic investments.

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

HealthCap investments breakdown analysis:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

HealthCap mostly invests with:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Investors with similar profile to HealthCap:

InvestorCriteria
Sweden Filip Engelbert
64%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 5
  • Active last 12 months: Yes
e.ventures
63%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Novo A/S
59%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Denmark Novo Seeds
59%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.8
Sweden FAM
59%
  • Range for average deal size: 10M - 20M USD
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Partech Ventures
57%
  • Range for average deal size: 10M - 20M USD
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Finland Fortum
56%
  • Range for average deal size: 10M - 20M USD
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Sweden PÄAB
56%
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United Kingdom Dawn Capital
56%
  • Range for average deal size: 10M - 20M USD
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2
  • Active last 12 months: Yes
Norway Ferd Capital
56%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes

News about HealthCap

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)